Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Mauck

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Plos One|October 29, 2014
A multi-compartment single and multiple dose pharmacokinetic comparison of rectally applied tenofovir 1% gel and oral tenofovir disoproxil fumarateKuo-Hsiung Yang, Craig Hendrix, Namandje Bumpus, et al.
Contraception|July 25, 2006
Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety studyJill L Schwartz, Christine Mauck, Jaim-Jou Lai, et al.
Contraception|January 17, 2024
Successful postcoital testing of Ovaprene: An investigational non-hormonal monthly vaginal contraceptiveChristine Mauck, Andrea Thurman, Jeffrey T Jensen, et al.
Plos One|October 29, 2014
Correlation between compartmental tenofovir concentrations and an ex vivo rectal biopsy model of tissue infectibility in the RMP-02/MTN-006 phase 1 studyNicola Richardson-Harman, Craig W Hendrix, Namandjé N Bumpus, et al.
AIDS (London, England)|May 13, 2006
Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected womenWafaa M El-Sadr, Kenneth H Mayer, Lisa Maslankowski, et al.
Clinical Therapeutics|April 25, 2023
Acceptability of Single-dose Clindamycin Gel for Bacterial Vaginosis: A Randomized Controlled TrialChristine Mauck, Sharon L Hillier, Judy Gendreau, et al.
AIDS Research and Human Retroviruses|April 19, 2019
The Effect of Hormonal Contraception on Cervicovaginal Mucosal End Points Associated with HIV AcquisitionAndrea Thurman, Neelima Chandra, Jill L Schwartz, et al.
Contraception|March 29, 2024
Safety testing of Ovaprene: An investigational nonhormonal monthly vaginal contraceptiveChristine Mauck, Andrea Thurman, Jeffrey T Jensen, et al.
AIDS Research and Human Retroviruses|September 5, 2012
RMP-02/MTN-006: A phase 1 rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of tenofovir 1% gel compared with oral tenofovir disoproxil fumaratePeter A Anton, Ross D Cranston, Angela Kashuba, et al.
Plos One|October 5, 2011
First phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 gel with a novel index of ex vivo efficacyPeter A Anton, Terry Saunders, Julie Elliott, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Plos One|October 29, 2014
A multi-compartment single and multiple dose pharmacokinetic comparison of rectally applied tenofovir 1% gel and oral tenofovir disoproxil fumarateKuo-Hsiung Yang, Craig Hendrix, Namandje Bumpus, et al.
Contraception|July 25, 2006
Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety studyJill L Schwartz, Christine Mauck, Jaim-Jou Lai, et al.
Contraception|January 17, 2024
Successful postcoital testing of Ovaprene: An investigational non-hormonal monthly vaginal contraceptiveChristine Mauck, Andrea Thurman, Jeffrey T Jensen, et al.
Plos One|October 29, 2014
Correlation between compartmental tenofovir concentrations and an ex vivo rectal biopsy model of tissue infectibility in the RMP-02/MTN-006 phase 1 studyNicola Richardson-Harman, Craig W Hendrix, Namandjé N Bumpus, et al.
AIDS (London, England)|May 13, 2006
Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected womenWafaa M El-Sadr, Kenneth H Mayer, Lisa Maslankowski, et al.
Clinical Therapeutics|April 25, 2023
Acceptability of Single-dose Clindamycin Gel for Bacterial Vaginosis: A Randomized Controlled TrialChristine Mauck, Sharon L Hillier, Judy Gendreau, et al.
AIDS Research and Human Retroviruses|April 19, 2019
The Effect of Hormonal Contraception on Cervicovaginal Mucosal End Points Associated with HIV AcquisitionAndrea Thurman, Neelima Chandra, Jill L Schwartz, et al.
Contraception|March 29, 2024
Safety testing of Ovaprene: An investigational nonhormonal monthly vaginal contraceptiveChristine Mauck, Andrea Thurman, Jeffrey T Jensen, et al.
AIDS Research and Human Retroviruses|September 5, 2012
RMP-02/MTN-006: A phase 1 rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of tenofovir 1% gel compared with oral tenofovir disoproxil fumaratePeter A Anton, Ross D Cranston, Angela Kashuba, et al.
Plos One|October 5, 2011
First phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 gel with a novel index of ex vivo efficacyPeter A Anton, Terry Saunders, Julie Elliott, et al.
Pageof 5